{
    "organizations": [],
    "uuid": "ac3ec478888301be81547cdc0c18db34abd4138c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moleculin-enters-agreement-with-bs/brief-moleculin-enters-agreement-with-bsp-pharmaceuticals-for-its-leukemia-drug-candidate-idUSFWN1S10YG",
    "ord_in_thread": 0,
    "title": "BRIEF-Moleculin Enters Agreement With BSP Pharmaceuticals For Its Leukemia Drug Candidate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Moleculin Biotech Inc:\n* MOLECULIN ENTERS AGREEMENT WITH BSP PHARMACEUTICALS FOR ITS LEUKEMIA DRUG CANDIDATE\n* MOLECULIN BIOTECH INC - ENGAGED BSP PHARMACEUTICALS S.P.A. TO BEGIN PREPARATIONS FOR COMMERCIAL SCALE PRODUCTION OF ANNAMYCIN DRUG PRODUCT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-24T20:32:00.000+03:00",
    "crawled": "2018-04-25T14:26:00.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "moleculin",
        "biotech",
        "inc",
        "moleculin",
        "enters",
        "agreement",
        "bsp",
        "pharmaceutical",
        "leukemia",
        "drug",
        "candidate",
        "moleculin",
        "biotech",
        "inc",
        "engaged",
        "bsp",
        "pharmaceutical",
        "begin",
        "preparation",
        "commercial",
        "scale",
        "production",
        "annamycin",
        "drug",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}